Cowen Remains Bullish on Galapagos NV (GLPG) After AbbVie (ABBV) Declined to Opt-In for Phase III Development of Filgotinib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. AMC
5. USO
6. NUAI
7. MSFT
8. ACN
9. AMZN
10. FFAI

Go back to Cowen Remains Bullish on Galapagos NV (GLPG) After AbbVie (ABBV) Declined to Opt-In for Phase III Development of Filgotinib
AbbVie (NYSE: ABBV) Delayed: 264.94 +0.98 (0.37%)
Previous Close $263.96    52 Week High $68.12 
Open $263.07    52 Week Low $50.71 
Day High $266.60    P/E 57.47 
Day Low $261.23    EPS $4.61 
Volume 583,830       

(NASDAQ: GLPG) Delayed: 27.73 --0 (-0%)
Previous Close $27.73    52 Week High $73.37 
Open $27.73    52 Week Low $37.03 
Day High $27.73    P/E N/A 
Day Low $27.73    EPS $0.00 
Volume 17,787